Ahmed S.A. Mady

A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth <i>In Vitro</i> and <i>In Vivo</i>

Fardokht A. Abulwerdi, Chenzhong Liao, Meilan Liu et al. · Molecular Cancer Therapeutics · 2013 · 181 citations · Full text

Chemoprevention Strategy, Cancer Biology, Tumor Biology +18

PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity

Joseph M. Gozgit, Melissa M. Vasbinder, Ryan Abo et al. · Cancer Cell · 2021 · 171 citations

Cytokine, Cancer Immunosurveillance, Medicine +9

3-Substituted-<i>N</i>-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation

Fardokht A. Abulwerdi, Chenzhong Liao, Ahmed S.A. Mady et al. · Journal of Medicinal Chemistry · 2014 · 78 citations · Full text

Immunology, Pharmaceutical Chemistry, Molecular Pharmacology +19

Wnt/β-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes

Jan W. Buikema, Ahmed S.A. Mady, Nikhil Mittal et al. · Development · 2013 · 64 citations · Full text

Cardiac Muscle, Cardiac Progenitor Cells, Normal Cardiac Development +27

The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics

William Giblin, Lauren Bringman-Rodenbarger, Angela H. Guo et al. · Journal of Clinical Investigation · 2021 · 43 citations · Full text

Immunology, Epigenetics, Melanoma Cells +16